Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Biochemistry|August 25, 2014
Evolving possible link between PI3K and NO pathways in neuroprotective mechanism of ischemic postconditioning in micePuja Gulati, Nirmal Singh
Canadian Journal of Physiology and Pharmacology|May 3, 2014
Tadalafil enhances the neuroprotective effects of ischemic postconditioning in mice, probably in a nitric oxide associated mannerPuja Gulati, Nirmal Singh
Journal of Pharmacy & Bioallied Sciences|November 18, 2014
Pharmacological evidence for connection of nitric oxide-mediated pathways in neuroprotective mechanism of ischemic postconditioning in micePuja Gulati, Nirmal Singh
The Journal of Surgical Research|September 10, 2013
Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injuryPuja Gulati, Nirmal Singh
The Journal of Surgical Research|March 25, 2014
Neuroprotective mechanism of ischemic postconditioning in mice: a possible relationship between protein kinase C and nitric oxide pathwaysPuja Gulati, Nirmal Singh
Pharmacology, Biochemistry, and Behavior|February 1, 2015
Investigation of the role of non-selective calcium channel blocker (flunarizine) on cerebral ischemic-reperfusion associated cognitive dysfunction in aged micePuja Gulati, Arunachalam Muthuraman, Parneet Kaur
The Journal of Surgical Research|January 21, 2014
Pharmacologic evidence for role of endothelial nitric oxide synthase in neuroprotective mechanism of ischemic postconditioning in micePuja Gulati, Nirmal Singh, Arunachalam Muthuraman
Infectious Disorders Drug Targets|October 15, 2025
Global Strategies for Combating Antimicrobial ResistancePrince Kumar, Puja Gulati, Mohita Thakur, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 12, 2012
Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia-reperfusion injuryPuja Gulati, Arunachalam Muthuraman, Amteshwar S Jaggi, et al.
CNS & Neurological Disorders Drug Targets|July 20, 2026
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical ConsiderationsTawqeer Shafi, Zora Singh, Puja Gulati, et al.
Pageof 2